Bio-Rad Laboratories (BIO-B) Other Accumulated Expenses (2009 - 2026)

Bio-Rad Laboratories (BIO-B) has 18 years of Other Accumulated Expenses data on file, last reported at $153.9 million in Q1 2026.

• Quarterly Other Accumulated Expenses rose 16.86% year-over-year to $153.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $153.9 million (up 16.86% YoY) and the FY2025 annual result came in at $141.7 million, down 3.74% from the prior year.
• Other Accumulated Expenses rose to $153.9 million in Q1 2026 per BIO-B's latest filing, from $141.7 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $212.7 million in Q2 2022 and bottomed at $127.8 million in Q3 2025.
• The 5-year median for Other Accumulated Expenses is $153.9 million (2026), against an average of $160.0 million.
• The widest annual swing landed in 2022, when Other Accumulated Expenses surged 37.29%; it then fell 21.85% in 2023.
• Tracing BIO-B's Other Accumulated Expenses over 5 years: stood at $169.6 million in 2022, then retreated by 4.74% to $161.6 million in 2023, then slipped by 8.91% to $147.2 million in 2024, then dropped by 3.74% to $141.7 million in 2025, then rose by 8.61% to $153.9 million in 2026.
• Per Business Quant, the three latest BIO-B Other Accumulated Expenses figures stand at $153.9 million (Q1 2026), $141.7 million (Q4 2025), and $127.8 million (Q3 2025).

Peer Comparison